KISSPEPTIN-10

Sexual Function & LibidoMixed Availability

Solid mechanistic understanding backed by human studies showing clear hormonal effects, though most research focuses on therapeutic applications rather than enhancement. The evidence is particularly strong for its role in puberty and reproductive function, but libido applications need more robust clinical trials.

Primarily studied by reproductive endocrinologists and researchers investigating hypogonadism, delayed puberty, and hypothalamic amenorrhea in clinical settings.

FDA Status
Research Only

Since Feb 2026

Evidence
Moderate
Studies

30 total, 4 human

What is KISSPEPTIN-10?

Originally identified as a regulator of the onset of puberty, this 10-amino acid fragment has become a focal point for researchers studying reproductive hormone dysfunction and sexual health disorders. The peptide acts as a master switch for the body's reproductive hormone cascade, making it particularly relevant for investigations into hypogonadism, fertility issues, and age-related sexual dysfunction. Its discovery helped explain why some individuals fail to enter puberty normally and opened new avenues for understanding libido regulation.

The peptide binds to GPR54 receptors in the hypothalamus, triggering a cascade that releases gonadotropin-releasing hormone (GnRH). This GnRH release then signals the pituitary gland to produce luteinizing hormone and follicle-stimulating hormone, which ultimately drive testosterone and estrogen production in the gonads. Think of it as pressing the 'start' button on the body's reproductive hormone factory—without this signal, the entire system remains dormant.

What the Research Shows

Decent foundation with 30 studies including 8 human trials, though only 2 randomized controlled trials limits the strength of clinical conclusions.

Among 30 total studies (8 human studies, 2 RCTs), kisspeptin-10 has been shown to increase luteinizing hormone pulse frequency in humans without desensitization during continuous infusion, while the kisspeptin-10/GPR54 system functions as an essential regulator of puberty onset and reproductive function through GnRH control. Additional evidence indicates the system's involvement in atherosclerosis progression, with GPR54 antagonism attenuating proatherosclerotic effects, and KISS1 demonstrates metastasis-suppressor properties through regulation of angiogenesis, autophagy, and apoptosis in cancer models.

Notable Studies

Direct comparison of the effects of intravenous kisspeptin-10, kisspeptin-54 and GnRH on gonadotrophin secretion in healthy men.

Jayasena CN, Abbara A, Narayanaswamy S et al. · Hum Reprod (2015)

RCT · Phase 1 · n=15 · 3 hours per session

Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men.

George JT, Veldhuis JD, Roseweir AK et al. · J Clin Endocrinol Metab (2011)

RCT · Phase 1 · n=622.5 hours

Correlation of Kisspeptin-10 level and fetal well-being in preeclamptic patients.

Ziyaraa MA, Hamdan FB, Mousa LR · Taiwan J Obstet Gynecol (2016)

Cohort · n=100

Reported Benefits

Libido research
Hormone axis stimulation2 studies
Reproductive function1 study

Regulatory Status

Research OnlyEffective: Feb 2026

Last verified: Feb 2026

Related Peptides

This information is for research purposes only and does not constitute medical advice. Always consult a licensed physician before using any peptides.